金石亚药：签订1500万元产品推广协议

Core Viewpoint - The company has signed a product promotion entrustment agreement for the drug Dinoprostone Ointment with its associate company, aiming to leverage both parties' strengths in products and channels, with no adverse impact on the company's future financial status and operating results [1] Group 1 - The agreement involves a transaction amount not exceeding 15 million yuan [1] - The promotion period is from the effective date of the agreement until December 31, 2026 [1] - The company holds a 32.43% stake in the associate company, Hangzhou Lingye Pharmaceutical [1] Group 2 - Zhejiang Kuaike Pharmaceutical will be responsible for the exclusive promotion of the product in national retail channels [1] - The transaction has been approved by the company's board of directors, with related directors abstaining from voting [1] - The agreement is expected to utilize the advantages of both parties effectively [1]